JOBS Act drives biotech IPO issuance

摘要

The impact of the Jumpstart Our Business Startups (JOBS) Act on capital formation cannot be ignored. More than two years since it was enacted, the legislation has provided a bridge to the public markets for small, venture-backed growth companies. There have already been 65 IPOs by venture-backed companies, putting full-year run-rate activity at 130, a lofty target that seems likely based on the growing pipeline of companies currently in registration. That compares with 81 in 2013 and 49 in 2012, based on data collected by the National Venture Capital Association and Thomson Reuters.